Abstract
Antibiotic disinfection of allograft heart valves is now an established procedure. A new low-concentration, broad-spectrum mixture of antibiotics was formulated and used successfully to disinfect 58 of 60 human aortic and pulmonary valves after 48 h exposure at 4 degrees C. The antibiotics included were cefoxitin 240 mcg/ml, lincomycin 120 mcg/ml, polymyxin B 100 mcg/ml, vancomycin 50 mcg/ml and amphotericin B 25 mcg/ml. Microorganisms isolated from experimental tissue and from clinical valves before treatment were tested for sensitivity to these antibiotics and were found to be sensitive to one or more. One isolate of Pseudomonas spp. showed decreased sensitivity to polymyxin B, and was found to have a minimum bactericidal concentration of 70 mcg/ml. Results indicated this antibiotic mixture had superior antibacterial efficiency to that in routine clinical use for the past 13 yr.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
